The Indian market, live
Ddev Plastiks Approves Investor Presentation; Earnings Call on Aug 11
Ddev Plastiks approved its Q1FY27 investor presentation. The company reported Q1FY27 revenue of ₹989 crore (up 29% YoY) and PAT of ₹64 crore (up 22% YoY). They are strategically entering the BESS market with a ₹150-200 crore investment for a 5 GWh assembly plant by Q1 FY28. An earnings call is scheduled for August 11, 2026.
JTL Industries Q1 FY27: Record Revenue of ₹722 Cr, EBITDA ₹59 Cr
JTL Industries reported record Q1 FY27 revenue of ₹722 crore and EBITDA of ₹59 crore. Sales volume grew 17.8% YoY to 1,18,513 metric tons. The company secured a ₹27 crore order for galvanized iron pipes. Capex for FY27 is ₹100 crore, with new capacity expected by H1 FY27. The firm aims for 50-60% value-added products and improved working capital cycle.
HPL Electric & Power Q1FY27 Revenue Surges 34% to ₹515 Crore; C&I Business Leads Growth
HPL Electric & Power reported a 34.52% YoY increase in Q1FY27 revenue to ₹515.24 crore. The C&I segment revenue grew 55% YoY to ₹277.59 crore. Smart Metering revenue rose 16.53% YoY to ₹237.65 crore. The company has an order book of over ₹3,200 crore. An investor meet is scheduled for August 11, 2026.
Saksoft Reports Consolidated Q1FY27 Revenue of ₹259.97 Crore, Net Profit ₹202.72 Crore
Saksoft Limited reported consolidated revenue from operations of ₹259.97 crore for Q1FY27. Net profit after tax was ₹202.72 crore. The company also announced a proposed merger of its subsidiary, Augmento Labs Private Limited, with Saksoft Limited.
Lloyds Metals Board Approves Q1 FY27 Results, Appoints Independent Director, and Green Energy Investments
Lloyds Metals and Energy Limited's Board approved Q1 FY27 results, reporting standalone revenue of ₹5,353.32 crore and profit after tax of ₹1,526.89 crore. Mr. Avijit Ghosh was appointed as an Independent Director for five years. The company also approved investments in renewable energy projects and strategic investments in subsidiaries, including up to ₹625 crore in Thriveni Earthmovers and Infra Private Limited.
Neuland Labs Q1FY27 Earnings Call Transcript Released
Neuland Laboratories Limited released its Q1 FY27 earnings call transcript. Total income rose 16.3% to ₹650.1 crores, with PAT at ₹147.4 crores. EBITDA was ₹231.1 crores (35.5% margin). The company expects 20% growth in FY27-FY28 and announced a strategic collaboration with Gland Pharma for sterile APIs.
Innovision Limited Secures ₹83.29 Crore Toll Collection Contract from NHAI
Innovision Limited has been awarded a one-year contract by NHAI to act as a user fee collection agency at Aashpur Fee Plaza on NH-91. The contract value is ₹83.29 crore and includes toll collection and facility maintenance for the Aligarh-Kanpur section.
PC Jeweller Q1FY27 Revenue Up 21% to ₹877 Crore; Debt-Free Status Expected This Quarter
PC Jeweller's Q1FY27 consolidated revenues grew 21% YoY to ₹877 crore. Operating EBITDA increased 90% to ₹242 crore, and Operating PAT rose 168% to ₹213 crore. The company is on track to become debt-free this quarter, having repaid 7 out of 14 consortium banks. A ₹1,000 crore QIP is planned for July 2026.
Bosch Q1 FY27 Revenue Up 22% to ₹5,842 Cr; PAT at ₹702 Cr
Bosch Limited reported Q1 FY27 revenue of ₹5,842 Cr, up 22.0% year-on-year. Profit Before Tax increased 12.0% to ₹939 Cr. Profit After Tax was ₹702 Cr. The growth was driven by strong demand in automotive segments. The company also highlighted recent acquisitions and joint ventures.
India Cements Chairman's Speech at 80th AGM Highlights Turnaround and Growth
The India Cements Limited reported a strong turnaround in FY 2025-26 with total income of ₹4,581 crore. Q1 FY27 saw a consolidated Profit After Tax of ₹27 crore, up from a loss of ₹133 crore. Sales volume grew 19% to 2.58 million tonnes, and EBITDA rose 72% to ₹159 crore. The company also highlighted sustainability initiatives and credit rating upgrades.
PC Jeweller Q1FY27 Consolidated Revenue Up 21% to ₹877 Crore; PAT Grows 168% to ₹213 Crore
PC Jeweller reported Q1 FY27 consolidated revenue of ₹877 crore, a 21% year-on-year increase. Consolidated Operating PAT surged 168% to ₹213 crore. The company is on track to become debt-free this quarter, having repaid significant portions of its bank debt. It also completed a ₹2,702 crore preferential issue and plans a ₹1,000 crore QIP.
KEI Industries Q1 FY27 Earnings Call Transcript Released
KEI Industries released its Q1 FY27 earnings call transcript. Net sales grew 23% to ₹3,185 crore, while EBITDA increased 39.5% to ₹415 crore and PAT rose 40% to ₹274 crore. Domestic sales were up 29%. The company anticipates over 20% growth in the next 2-3 years, supported by robust demand.
HCG Q1 FY27 Earnings Call Transcript Released; Revenue Up 13% to ₹695.1 Crore
HCG reported Q1 FY27 revenue of ₹695.1 crore, up 13% YoY, driven by an 11% increase in patient volumes. Adjusted EBITDA grew 20% to ₹133.9 crore, with margins improving to 19.4%. The new North Bangalore hospital contributed ₹6.7 crore in its first quarter. HCG aims for 24-25% EBITDA margins in the coming years.
CORONA Remedies Q1 FY27 Earnings Call Transcript Released
CORONA Remedies reported Q1 FY27 revenue of ₹422 Cr, up 21.9% YoY. EBITDA grew 33.5% to ₹93 Cr, and PAT increased 30.1% to ₹60 Cr. The company outperformed the IPM with 22.7% India business growth. Management reaffirmed FY27 guidance of 15% organic revenue growth and 20% PAT growth.
Lumax Auto Technologies Q1 FY27 Revenue Up 33% to ₹1,364 Cr; EBITDA Surges 51%
Lumax Auto Technologies reported Q1 FY27 consolidated revenues of ₹1,364 crore, up 33% YoY. EBITDA increased by 51% to ₹205 crore, with margins expanding 190 bps to 15.1%. PBT rose 78% to ₹132 crore. The company targets a 20% revenue CAGR and 20%+ EBITDA margin in its new mid-term plan.
JK Tyre CMD's Statement at 73rd AGM Highlights FY26 Growth & Expansion
JK Tyre's CMD statement at the 73rd AGM revealed FY26 consolidated revenues of ₹16,384 crore, up 11%, and PAT of ₹774 crore, up 50%. The company commissioned projects worth ₹1,400 crore, with ₹1,130 crore ongoing and ₹4,980 crore approved for capacity expansion. Sustainability efforts include a 50% reduction in carbon emissions.
IOL Chemicals Q1 FY27 Revenue Surges 37.1% to ₹756.3 Cr, PAT Jumps 89.9%
IOL Chemicals reported record Q1 FY27 results with revenue up 37.1% to ₹756.3 crore and PAT up 89.9% to ₹64.5 crore. Pharmaceuticals revenue grew 43% YoY, driven by non-Ibuprofen APIs. Chemicals revenue increased 29% YoY. Exports contributed 28.5% of revenue. Clopidogrel API received NMPA approval in China.
Elin Electronics Q1 FY27 Earnings Call Transcript Released
Elin Electronics Q1 FY27 revenues rose 23% to ₹362.8 crore. However, EBITDA fell to ₹4 crore due to commodity price hikes and a Rupee depreciation. A fire at the Ghaziabad plant caused a ₹24.6 crore loss, covered by insurance. The company forecasts FY27 revenue of ₹1375 crore, prioritizing margins.
Energy Development Company Limited Board Meeting Outcome - Aug 10, 2026
Energy Development Company Limited announced its Q1 FY27 results on August 10, 2026. The company reported significant concerns highlighted by auditors regarding its standalone and consolidated financial results for the quarter ended June 30, 2026. Issues include doubtful receivables, un-recognized interest, and substantial income tax demands.
Yatharth Hospital Board Approves Q1 FY27 Results, Interim Dividend, and ESOP Scheme
Yatharth Hospital announced Q1 FY27 results, reporting standalone revenue of ₹1,763.08 million and consolidated revenue of ₹3,926.54 million. The company declared an interim dividend of ₹0.50 per share, with a record date of August 14, 2026. An ESOP 2026 scheme was approved, and M/s Subodh Kumar & Co. re-appointed as Cost Auditor. Additionally, the company acquired a 250-bed under-construction hospital in Gurugram for ₹1,000 million (₹100 crore).
NINtec Systems Q1FY27: Revenue Up 18.1%, Operating Profit Soars 40.9% to ₹11.88 Cr
NINtec Systems reported Q1 FY27 consolidated results with revenue up 18.1% YoY to ₹45.86 Cr and operating profit up 40.9% YoY to ₹11.88 Cr. Net profit rose 20.2% to ₹9.20 Cr, and EPS increased to ₹4.95. Employee costs decreased by 4.8% YoY. The company highlighted its Al-first delivery model's impact on margin expansion.
Lumax Auto Technologies Approves Q1 Results, New Plant, and Guarantees
Lumax Auto Technologies Limited announced its Q1 FY27 results, with approved standalone and consolidated financials. The company will provide guarantees up to ₹8 Crores for Lumax FAE Technologies. A new manufacturing plant for the IAC Division will be set up in Chakan with a capex of ₹156.23 Crores, expected to be commissioned by Q4 FY27 and Q1 FY28.
Fusion Finance Q1 FY27: PBT surges 67% QoQ to ₹62 Cr, NIM at 11.9%
Fusion Finance reported strong Q1 FY27 results with PBT surging 67% QoQ to ₹62 crore. NIM improved to 11.93%, and Gross NPA decreased to 2.51%. The company's CRAR stood at 36.95%, and it maintained liquidity of ₹1,880 crore. The MD & CEO highlighted a disciplined approach for responsible scaling.
Dollar Industries Q1 FY27 PAT Jumps 22.1% YoY to ₹2,602 Lacs
Dollar Industries reported Q1 FY27 consolidated PAT of ₹2,602 Lacs, a 22.1% YoY increase. Total income was ₹40,566 Lacs. Gross Profit Margin improved to 37.4% and Operating EBITDA grew 11.4% YoY to ₹4,777 Lacs. "Dollar Protect" segment saw 49% value growth. Phase 2 of "Project Lakshya" commenced.
Ddev Plastiks Q1 FY27 Revenue ₹989.45 Crore, Profit ₹637.93 Crore
Ddev Plastiks reported Q1 FY27 revenue of ₹989.45 crore and profit of ₹637.93 crore. The Board approved the Q1 results, an investor presentation, and an addendum to the AGM notice due to Mrs. Rajni Mishra's appointment as an Additional Director. The BESS project will be relocated to Kolkata.
Fusion Finance Q1 FY27 Results: PBT Rs 62 Cr, AUM Rs 7,702 Cr, NIM 11.93%
Fusion Finance Limited reported Q1 FY27 results with PBT at ₹62 Cr (up 67% QoQ) and AUM at ₹7,702 Cr (up 4% QoQ). NIM improved to 11.93%, and PPOP rose 10% QoQ to ₹102 Cr. Disbursements grew 88% YoY to ₹1,783 Cr. GNPA improved to 2.51%, and credit costs fell 29% QoQ to ₹40 Cr.
Jupiter Wagons Secures Orders Worth Over ₹211 Crore from JSW Port Logistics & OASPL
Jupiter Wagons Limited secured new orders worth over ₹211 crore. This includes a ₹147.11 crore order from JSW Port Logistics for 329 wagons and a ₹64.16 crore order from Orissa Alloy Steel Private Limited for 150 wagons. The company sees continued opportunities in India's growing freight logistics sector.
Precision Wires Approves Q1 FY27 Results, Rs 150 Cr CCD Issue, Capex Hike, & CFO Change
Precision Wires India Limited approved Q1 FY27 un-audited financial results. The Silvassa expansion project capacity is revised to 4620 MT/PA at ₹38 Cr cost. Mrs. Krina Parekh appointed CFO, replacing Mr. Mohandas Pai. The company will issue 37.5 lakh CCDs worth ₹150 Cr and secured a ₹200 Cr working capital facility from IDFC First Bank.
Lumax Auto Technologies Q1 FY27 Results: Profit Up, New Plant Capex ₹156 Cr
Lumax Auto Technologies reported Q1 FY27 results with standalone revenue at ₹1,00,924.81 Lakhs and consolidated revenue at ₹1,36,361.57 Lakhs. The company approved a ₹156.23 Crore capex for a new plant in Chakan, Maharashtra, expected to generate ₹440 Crore turnover. A corporate guarantee of up to ₹8 Crores was issued for its subsidiary, Lumax FAE Technologies Private Limited.
NOCIL Q1 FY27 Revenue Jumps 20% YoY to ₹403 Crore; EBITDA Up 48%
NOCIL Limited reported a 20% YoY revenue growth to ₹403 crore for Q1 FY27, driven by 9% volume growth and higher selling prices. EBITDA surged 48% YoY to ₹45 crore, with margins at 11.2%. PAT increased 61% YoY to ₹28 crore. The company expects FY27 revenue between ₹1,400-₹1,600 crore.
Wockhardt Q1 FY27 PAT at ₹107 Cr, Revenue Surges 26% to ₹929 Cr
Wockhardt's Q1 FY27 PAT surged to ₹107 crore from a loss of ₹108 crore in Q1 FY26. Revenue grew 26% to ₹929 crore, and EBITDA increased 86% to ₹188 crore. Biotech operations grew 112% to ₹236 crore. Key product Zaynich® received US FDA approval.
Lumax Auto Technologies Approves Q1 Results, New Plant Capex of ₹156.23 Cr
Lumax Auto Technologies approved its Q1 FY27 results. The company will invest approximately ₹156.23 Crores to set up a new manufacturing plant in Chakan, Maharashtra, for its IAC Division, expected to generate ₹440 Crores in turnover. Additionally, a corporate guarantee of up to ₹8 Crores was approved for its subsidiary, Lumax FAE Technologies.
Yatharth Hospitals Q1FY27 Revenue Surges 51% YoY to ₹392.7 Crore; Declares Maiden Dividend
Yatharth Hospitals reported Q1FY27 revenue of ₹392.7 crore, up 51% YoY, and EBITDA of ₹91.7 crore, up 39% YoY. PAT stood at ₹45.4 crore, up 8% YoY. The company declared its maiden interim dividend of 5% and approved new ESOP schemes. Faridabad Sector-20 achieved EBITDA breakeven.
JSW Energy adds 1,166 MW Renewable & 300 MW Thermal Capacity; Total Capacity Reaches 14,920 MW
JSW Energy added 1,166 MW renewable and 300 MW thermal capacity since April 2026, reaching 14,920 MW total installed capacity. Renewable energy constitutes 60% of its portfolio. The company targets 30 GW generation capacity by 2030 and carbon neutrality by 2050.
Gland Pharma Q1FY27 Results: Revenue up 20% to ₹18,003 Cr, PAT grows 47%
Gland Pharma reported Q1FY27 revenue of ₹18,003 crore, up 20% YoY. PAT grew 47% to ₹3,170 crore. CDMO revenue increased 20% and B2B revenue rose 19%. The company launched 4 molecules in the USA and filed 3 ANDAs. Strategic collaborations and in-licensing agreements were also highlighted.
Astra Microwave Q1 FY27 Revenue Down 11.5% to ₹177 Cr; Secures ₹2,205 Cr HAL Order
Astra Microwave Products Limited reported Q1 FY27 unaudited results with standalone revenue at ₹176 crore (down 10.7%) and consolidated revenue at ₹177 crore (down 11.5%). The company secured a significant ₹2,205 crore order from HAL in July 2026. The standalone order book stands at ₹2,156 crore and consolidated at ₹2,849 crore.
Yatharth Hospital Declares ₹0.50 Interim Dividend, Approves ESOP 2026
Yatharth Hospital declared an interim dividend of ₹0.50 per share, with a record date of August 14, 2026. The company approved its Q1 FY27 unaudited financial results and the ESOP 2026 scheme. Consolidated revenue was ₹392.65 crore, and profit after tax was ₹45.42 crore. The company also acquired a 250-bed hospital in Gurugram for ₹100 crore.
Gland Pharma Q1FY27 Revenue Up 20% to ₹18,003 Cr, PAT Jumps 47%
Gland Pharma reported Q1 FY27 results with revenue at ₹18,003 crore, up 20% YoY. PAT surged 47% to ₹3,170 crore. Both CDMO and B2B segments grew robustly. The company launched 4 new molecules in the USA and anticipates significant revenue from a new CDMO partnership starting in 2029.
Patel Engineering Q1 FY27 Revenue Up 3.8% to ₹12,807 Mn; PAT Jumps 24.5%
Patel Engineering reported Q1 FY27 Revenue from Operations of ₹12,807 Mn, up 3.8% YoY. PAT increased 24.5% YoY to ₹935 Mn, with Diluted EPS at ₹0.94. The company's credit rating was upgraded to 'A' in June 2026. The total order book is ₹1,46,356 Mn.
Equitas Small Finance Bank Announces 10th AGM on Sep 9, 2026; Approves QIP Up to ₹1250 Cr
Equitas Small Finance Bank's 10th AGM is scheduled for September 9, 2026. The bank plans to raise up to ₹1250 Crore via QIP and ₹500 Crore via debt instruments. Key appointments include re-appointment of MD & CEO Vasudevan P N and Director Balaji Nuthalapadi. Auditors M/s. Sundaram & Srinivasan to be appointed.
Capillary Technologies Q1 FY27 Earnings Call Transcript Released
Capillary Technologies reported Q1 FY27 revenue of ₹256 crore, up 43% YoY, with EBITDA at ₹44 crore, up 132%. Normalized PAT was ₹25 crore. NRR stood at 111%, and new ACV grew 75% YoY. The SessionM acquisition is progressing, turning profitable and generating ₹5-6 crore cash. AI product aiRA is gaining traction, with a revenue run rate of $2-2.5 million.
Windlas Biotech Q1FY27 Revenue up 18% to ₹248 Crore; PAT at ₹25 Crore
Windlas Biotech reported Q1FY27 revenue of ₹248 crore, an 18% YoY increase, marking its 14th consecutive quarter of record revenue. Adjusted PAT grew 37% YoY to ₹25 crore. The company completed a ₹47 crore buyback and declared a ₹13 crore dividend for FY26. Generic Formulations CDMO revenue rose 29% YoY.
Vijaya Diagnostic Centre Q1 FY27 Earnings Call Transcript Released
Vijaya Diagnostic Centre reported Q1 FY27 revenue growth of 22.8% to ₹231 crore, with PAT up 37.6% to ₹53 crore. EBITDA rose 34% to ₹98 crore, with margins at 42.7%. The company commissioned new hubs and spokes, including advanced imaging in Bengaluru. Capex for expansion is estimated at ₹190-195 crore, including land acquisition in AP.
Capillary Technologies Q1 FY27 Earnings Call Transcript Released
Capillary Technologies released its Q1 FY27 earnings call transcript. Revenue grew 43% YoY to ₹256 crore, with EBITDA up 132% to ₹44 crore. Normalized PAT was ₹25 crore. NRR stood at 111% and new ACV grew 75% YoY. The company is integrating the SessionM acquisition and leveraging AI with its aiRA platform.
Shilpa Medicare Q1 FY27: Highest Ever Revenue & EBITDA, PAT Surges 115%
Shilpa Medicare reported record Q1 FY27 revenue of ₹469 cr (up 43% YoY) and EBITDA of ₹139 cr (up 42% YoY). PAT surged 115% YoY to ₹101 cr. The company's credit rating was upgraded to AA-. Key growth drivers include API, Formulation, and Biologics divisions. Management expects continued robust growth and improved margins.
KKCL Q1 FY27 Revenue Up 19% to ₹279 Crore, PAT Grows 29%
Kewal Kiran Clothing Limited (KKCL) reported Q1 FY27 consolidated revenue of ₹279 crore, up 19% YoY, driven by 24% volume growth. EBITDA increased 29% to ₹52 crore, with margins at 19%. PAT grew 29% to ₹41 crore. The company aims for a 20% CAGR by FY28.
CMR Green Technologies Q1 FY27 Results: Revenue Surges 64.9% YoY to ₹3,122.7 Cr
CMR Green Technologies reported Q1 FY27 results with revenue up 64.9% YoY to ₹3,122.7 crore. EBITDA increased 27.1% to ₹139.5 crore and PAT rose 21.9% to ₹68.2 crore. Sales volume grew 25.2% to 1,12,336 MT. The company invested ₹53 crore in expansion projects and aims to reach over 7 lakh tonnes annual capacity by FY27.
UNO Minda Q1 FY27 Earnings Call Transcript Released
UNO Minda reported Q1 FY27 consolidated revenue of ₹5,557 crore, up 26% YoY. EBITDA grew 21% to ₹572 crore, with margins at 10.3%. PAT increased 24% to ₹296 crore. Key segments like Casting and Green Mobility showed significant growth. The company plans ₹1,750 crore capex for FY27 and ₹320 crore for a new seating facility.
Shree Ram Proteins Board Approves Sale of Undertaking for ₹17 Crore
Shree Ram Proteins' Board approved the sale of substantially the whole undertaking for approximately ₹17 crore. Shareholder approval will be sought via postal ballot. Ms. Payal Dhamecha appointed as Scrutinizer for the postal ballot process.
INOX India Q1 FY27 Earnings Call Transcript Released
INOX India reported record Q1 FY27 order inflow of ₹532 crore, with the total order book at ₹1,686 crore. Total income grew 8.3% YoY to ₹382 crore, while EBITDA was ₹90 crore. Key wins include orders from the space exploration sector and CERN. The company also secured aerospace quality certification and advanced its semiconductor and water solutions initiatives.
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio
Summaries are generated from primary exchange filings and are for information only, not a recommendation to buy or sell. Also available as an RSS feed. For the live index overview and the Market Mood Index, see Markets; for model portfolios you can actually follow, see Discover.